Senti Biosciences (SNTI) Stock Chart & Stock Price History $2.33 +0.08 (+3.56%) (As of 11/14/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Senti Biosciences Stock Price Performance5 Day Performance+9.91%1 Month Performance+9.91%3 Month Performance+7.37%6 Month Performance-38.03%Year-To-Date Performance-64.70%1 Year Performance-33.43% Receive SNTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. SNTI Stock Chart for Thursday, November, 14, 2024 SNTI Chart by TradingView Senti Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/13/2024$2.27$2.25-0.88%$2.40$2.255,286 shs$10.31 million11/12/2024$2.24$2.27+1.34%$2.30$2.167,790 shs$10.39 million11/11/2024$2.12$2.24+5.66%$2.32$2.137,346 shs$10.26 million11/08/2024$2.20$2.12-3.64%$2.20$2.1218,427 shs$9.71 million11/07/2024$2.17$2.20+1.38%$2.30$2.203,540 shs$10.08 million11/06/2024$2.30$2.17-5.65%$2.33$2.1180,513 shs$9.94 million Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/05/2024$2.24$2.30+2.68%$2.43$2.2211,364 shs$10.53 million11/04/2024$2.18$2.24+2.75%$2.45$2.1695,023 shs$10.26 million11/01/2024$2.17$2.18+0.46%$2.22$2.106,557 shs$9.98 million10/31/2024$2.16$2.17+0.46%$2.19$2.171,755 shs$9.94 million10/30/2024$2.22$2.16-2.70%$2.23$2.163,715 shs$98.83 million10/29/2024$2.24$2.22-0.89%$2.35$2.112,686 shs$101.58 million10/28/2024$2.15$2.24+4.19%$2.36$2.126,276 shs$102.49 million10/25/2024$2.13$2.15+0.94%$2.22$2.1521,639 shs$98.37 million10/24/2024$2.31$2.13-7.79%$2.25$2.1217,408 shs$97.46 million10/23/2024$2.28$2.31+1.32%$2.32$2.167,383 shs$105.69 million10/22/2024$2.26$2.28+0.88%$2.37$2.284,126 shs$104.32 million10/21/2024$2.28$2.26-0.88%$2.38$2.204,748 shs$103.41 million10/18/2024$2.15$2.28+6.05%$2.36$2.1412,819 shs$104.32 million10/17/2024$2.19$2.15-1.83%$2.29$2.0343,519 shs$98.37 million10/16/2024$2.04$2.19+7.61%$2.32$2.0612,165 shs$100.20 million10/15/2024$2.12$2.04-4.00%$2.15$2.024,195 shs$93.12 million10/14/2024$2.15$2.12-1.40%$2.63$2.0071,559 shs$97.00 million10/11/2024$2.11$2.15+1.90%$2.21$2.0820,900 shs$98.37 million10/10/2024$2.18$2.11-3.21%$2.21$2.0816,546 shs$96.54 million10/09/2024$2.38$2.18-8.40%$2.56$2.1870,728 shs$99.75 million10/08/2024$2.41$2.38-1.24%$2.43$2.2315,419 shs$108.90 million10/07/2024$2.24$2.41+7.59%$2.48$2.2125,937 shs$110.27 million10/04/2024$2.20$2.24+1.82%$2.24$2.1113,863 shs$102.49 million10/03/2024$2.15$2.20+2.33%$2.26$2.0511,037 shs$100.66 million10/02/2024$2.26$2.15-4.87%$2.46$2.0823,686 shs$98.37 million10/01/2024$2.26$2.26$2.34$2.1625,034 shs$103.41 million09/30/2024$2.26$2.26$2.29$2.0540,596 shs$103.41 million09/27/2024$2.28$2.26-0.88%$2.30$2.218,877 shs$103.41 million09/26/2024$2.30$2.28-0.87%$2.32$2.1847,478 shs$104.32 million09/25/2024$2.93$2.30-21.50%$2.85$2.3049,783 shs$105.24 million09/24/2024$3.09$2.93-5.18%$3.28$2.8439,807 shs$134.06 million09/23/2024$3.15$3.09-1.90%$3.26$3.0911,215 shs$141.38 million09/20/2024$3.13$3.15+0.56%$3.29$3.117,266 shs$144.13 million09/19/2024$3.09$3.13+1.38%$3.25$3.066,767 shs$143.33 millionElon Musk has put himself in their crosshairs (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary.09/18/2024$3.11$3.09-0.64%$3.20$3.068,514 shs$141.38 million09/17/2024$2.92$3.11+6.51%$3.27$2.7923,753 shs$142.30 million09/16/2024$3.07$2.92-4.89%$3.08$2.917,575 shs$133.61 million09/13/2024$3.10$3.07-0.97%$3.13$2.8311,114 shs$14.06 million09/12/2024$3.04$3.10+1.97%$3.14$2.9710,952 shs$141.84 million09/11/2024$2.84$3.04+7.04%$3.06$2.8112,418 shs$139.10 million09/10/2024$2.89$2.84-1.73%$2.98$2.841,709 shs$13.01 million09/09/2024$2.87$2.89+0.70%$3.10$2.8424,797 shs$13.24 million09/06/2024$2.95$2.87-2.71%$2.95$2.797,850 shs$131.32 million09/05/2024$2.74$2.95+7.66%$2.98$2.7718,413 shs$134.98 million09/04/2024$2.63$2.74+4.18%$2.75$2.699,883 shs$125.37 million09/03/2024$2.65$2.63-0.75%$2.71$2.604,894 shs$120.34 million09/02/2024$2.65$2.65$2.75$2.596,900 shs$121.25 million08/30/2024$2.71$2.65-2.21%$2.75$2.596,993 shs$121.25 million08/29/2024$2.58$2.71+5.24%$2.83$2.6011,013 shs$124.00 million08/28/2024$2.74$2.58-6.02%$2.79$2.5211,444 shs$117.82 million08/27/2024$2.78$2.74-1.44%$2.82$2.7111,675 shs$125.37 million08/26/2024$2.89$2.78-3.81%$2.88$2.6827,354 shs$127.20 million08/23/2024$2.68$2.89+7.84%$2.98$2.65114,044 shs$132.23 million08/22/2024$2.60$2.68+3.08%$2.79$2.5660,257 shs$122.62 million08/21/2024$2.09$2.60+24.40%$2.60$2.0257,007 shs$118.96 million08/20/2024$2.11$2.09-0.95%$2.34$2.0616,186 shs$95.63 million08/19/2024$2.31$2.11-8.66%$2.30$2.1070,262 shs$96.54 million08/16/2024$2.29$2.31+0.87%$2.39$2.2525,119 shs$105.69 million08/15/2024$2.17$2.29+5.53%$2.38$2.1977,238 shs$104.78 million08/14/2024$1.96$2.17+10.71%$2.19$1.9992,109 shs$99.29 million08/13/2024$1.78$1.96+10.11%$1.97$1.7231,130 shs$89.68 million Related Companies Carisma Therapeutics Stock Price Chart Achilles Therapeutics Stock Price Chart Passage Bio Stock Price Chart Elevation Oncology Stock Price Chart CERo Therapeutics Stock Price Chart DURECT Stock Price Chart Lantern Pharma Stock Price Chart Daré Bioscience Stock Price Chart CalciMedica Stock Price Chart OKYO Pharma Stock Price Chart Receive SNTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNTI) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredBreaking News: Are Trump/Musk Planning an AI Takeover? (Shocking)Now that he is Donald Trump’s right-hand man… You owe it to yourself to see Elon Musk’s big AI prediction f...Traders Agency | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
